Physicians, nurses, and other medical professionals often face an awkward situation when it comes to smoking or alcohol: You ask your patient about his or her smoking or drinking – or skate around a potential addiction problem – only to not gather a real answer. Patient self-reporting is notoriously unreliable.
One way to improve the poor success rate of substance-abuse treatment is by removing this communication barrier for clinicians. By quickly receiving accurate, detailed information about a patient’s smoking or drinking, you can avoid self-report errors and move directly to focusing on the test results and the reasons that treatment may not be working (too many side effects, social pressure, medication costs are too high, etc.). Our technology helps you reliably monitor the recovery process so you can intervene early if a relapse occurs – rather than waiting for the patient to admit that things are out of control.
With our tools, you can measure success or failure quickly and accurately, and even reward patients for truly breaking bad habits like smoking or heavy drinking.
Behavioral Diagnostics has also identified DNA-based epigenetic biomarkers for the diagnosis, treatment, and prevention of illnesses and diseases, such as depression, that can be caused by a substance-abuse problem. Epigenetic analysis helps you overcome the limits of genetic testing for precise diagnosis and management, allowing you to select the right drugs and treatments at the right time for each patient.